References
Mayer H, Bollag W, Hanni R, Ruegg R: Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology. Experientia 34:1105–1119, 1978
Dickens CH: Retinoids: A review. J Am Acad Dermatol 11:541–552, 1984
Frederiksson T: Antipsoriatic activity of retinoic acid (vitamin A acid). Dermatologica 142:133–136, 1971
Jarrett A, Spearman R: Vitamin A and the skin. Br J Dermatol 82:197–199, 1970
Russell R, Boyer J, Baggheri S, Hruban Z: Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 291:435–461, 1974
Hruban Z, Russell R, Boyer J, Glagov S, Bagheri S: Ultrastructural changes in livers of two patients with hypervitaminosis A. Am J Pathol 76(3):451–461, 1974
Dahl B, Mollenbach K, Reymann F: Treatment of psoriasis vulgaris with a new retinoic acid derivative Ro 10-9359. Dermatologica 154:261–267, 1977
Fredriksson T: Oral treatment of psoriasis and pustulosis palmoplantaris with Ro 10-9359. Dermatologica 157(Suppl 1):13–18, 1978
Glazer S, Roenigk H, Yokoo H, Sparberg M: A study of potential hepatoxicity of etretinate used in the treatment of psoriasis. J Am Acad Dermatol 6:63–687, 1982
Glazer S, Roenigk H, Yokoo H, Sparberg M, Pravicini U: Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate. J Am Acad Dermatol 10:632–638, 1984
Roenigk H, Gibstine C, Glazer S, Sparberg M, Yokoo H: Serial liver biopsies in psoriatic patients receiving long-term etretinate. Br J Dermatol 112:77–81, 1985
Orfanos C, Mahrle G, Goerz G, Happle R, Hofbauer M, Landes E, Schimpf A: Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment. Dermatologica 159:62–70, 1979
Orfanos C, Bauer E: Evidence for anti-inflammatory activities of oral synthetic retinoids: Experimental findings and clinical experience. Br J Dermatol 109(Suppl 25):55–60, 1983
Fredriksson R, Pettersson U: Oral treatment of pustulosis palmoplantaris with a new retinoid: Ro 10-9359. Dermatologica 158:60–64, 1979
Thune P, Mork N: A case of centrolobular toxic necrosis of the liver due to aromatic retinoid—Tigason (Ro 10-9359). Dermatologica 160:405–408, 1980
Weiss V, Layden T, Spinowitz A, Buys C, Nemchausky B, West D, Emmons K: Chronic active hepatitis associated with etretinate therapy. Br J Dermatol 112:591–597, 1985
Foged E, Jacobsen F: Side effects due to Ro 10-9359. Dermatologica 164:395–403, 1982
van Voorst Vader P, Houthoff H, Effink H, Gips C: Etretinate (Tigason) hepatitis in 2 patients. Dermatologica 168:41–46, 1984
Gavish D, Katz M, Gottehrer N, Israeli A, Lijovetzky G, Holubar K: Cholestatic jaundice, an unusual side effect of etretinate. J Am Acad Dermatol 13(4):669–670, 1985
Weiss V, West D, Ackerman R, Robinson L: Hepatotoxic reactions in a patient treated with etretinate. Arch Dermatol 120:104–106, 1984
Zimmerman HJ: Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver. Appleton-Century-Crofts, New York, 1978, pp 349–369
Ishak KG, Irey NS: Hepatic injury associated with phenothiazines: Clinicopathologic and follow-up study of 36 patients. Arch Pathol 93:283, 1972
Paravicini U, Stocket K, MacNamara PJ, Hanni R, Busslinger A: On metabolism and pharmacokinetics of an aromatic retinoid. Ann NY Acad Sci 359:54–67, 1981
Camuto P, Shupack J, Orbuch P, Tobias H, Sidhu G, Feiner H: Long-term effects of etretinate on the liver in psoriasis. Am J Surg Pathol 11(1):30–37, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khouri, M.R., Saul, S.H., Dlugosz, A.A. et al. Hepatocanalicular injury associated with vitamin A derivative etretinate. Digest Dis Sci 32, 1207–1211 (1987). https://doi.org/10.1007/BF01300208
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01300208